Skip to main content
Log in

Assessing Patterns of Practice of Sentinel Lymph Node Biopsy for Breast Cancer in Latin America

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Introduction

There is a lack information regarding how sentinel lymph node biopsy (SLNB) for breast cancer is carried out today in developing countries and how it was adapted. To rectify this situation we performed a pattern-of-practice survey amongst practicing surgeons in Latin America (LA).

Methods

A survey was developed to assess current surgical practice in breast cancer, use of SLNB, limitations to the implementation, training, technique variations, and observed adverse events. A total of 30 surgical associations and breast surgery societies in 18 Latin American countries were invited to participate. Surveys were distributed among member of these associations and 76.7 % of those contacted answered the survey. Responses were limited only to those who reported treating breast cancer patients.

Results

A total of 463 surgeons who manage breast cancer responded. Over 53 % of surgeons do not have sub-specialty training. Only 47.7 % have a high-volume case load, of which 87.8 % routinely perform SLNB. The main limitations perceived to the implementation of SLNB were a lack of resources/equipment (48 %) and training opportunities (33 %). Over 60 % reported that fewer than half of their patients were eligible for SLNB and 67.8 % reported that they were involved in teaching this technique to residents.

Conclusions

A significant proportion of surgeons that treat breast cancer cases in LA have not had sub-specialty training or manage a low volume of cases. Among those surgeons with a high-volume caseload, SLNB is routinely performed. SLNB training during residency represents an opportunity for improvement in the region.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D, editors (2012) Globocan 2008: cancer incidence and mortality worldwide. IARC CancerBase No. 10

  3. Parkin DM, Fernandez LM (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(Suppl 1):S70–S80

    Article  PubMed  Google Scholar 

  4. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  5. Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C (2005) Trends in cancer mortality in the Americas, 1970–2000. Ann Oncol 16:489–511

    Article  CAS  PubMed  Google Scholar 

  6. Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133–140

    Article  CAS  PubMed  Google Scholar 

  7. Schwartsmann G (2001) Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol 19:118S–124S

    CAS  PubMed  Google Scholar 

  8. Lozano-Ascencio R, Gomez-Dantes H, Lewis S, Torres-Sanchez L, Lopez-Carrillo L (2009) Breast cancer trends in Latin America and the Caribbean. Salud Publica Mex 51(Suppl 2):s147–s156

    Article  PubMed  Google Scholar 

  9. Reyes-Ortiz CA, Freeman JL, Pelaez M, Markides KS, Goodwin JS (2006) Mammography use among older women of seven Latin American and Caribbean cities. Prev Med 42:375–380

    Article  PubMed Central  PubMed  Google Scholar 

  10. Forouzanfar MH, Foreman KJ, Delossantos AM et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378:1461–1484

    Article  PubMed  Google Scholar 

  11. Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97:72–81

    Article  CAS  PubMed  Google Scholar 

  12. Baquet CR, Commiskey P (2000) Socioeconomic factors and breast carcinoma in multicultural women. Cancer 88:1256–1264

    Article  CAS  PubMed  Google Scholar 

  13. Robles SC, Galanis E (2002) Breast cancer in Latin America and the Caribbean. Rev Panam Salud Publica 11:178–185

    Article  PubMed  Google Scholar 

  14. Buccimazza I (2011) Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities. World J Surg 35:1155–1158. doi:10.1007/s00268-011-0956-3

    Article  Google Scholar 

  15. Rescigno J, Zampell JC, Axelrod D (2009) Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol 16:687–696

    Article  PubMed  Google Scholar 

  16. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398 (discussion 398–401)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553

    Article  PubMed  Google Scholar 

  18. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–339 (discussion 340)

    Article  CAS  PubMed  Google Scholar 

  19. Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 339:941–946

    Article  CAS  PubMed  Google Scholar 

  20. Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720

    Article  PubMed  Google Scholar 

  21. Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345–2350

    CAS  PubMed  Google Scholar 

  22. Bafford A, Gadd M, Gu X, Lipsitz S, Golshan M (2010) Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma. Am J Surg 200:374–377

    Article  PubMed  Google Scholar 

  23. Wilke LG, McCall LM, Posther KE et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13:491–500

    Article  PubMed  Google Scholar 

  24. Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98:599–609

    Article  PubMed  Google Scholar 

  25. McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213–5219

    Article  PubMed Central  PubMed  Google Scholar 

  26. No authors listed (2009) Breast cancer in developing countries. Lancet 374:1567

    Article  Google Scholar 

  27. McDermott AM, Wall DM, Waters PS et al (2013) Surgeon and breast unit volume–outcome relationships in breast cancer surgery and treatment. Ann Surg 258(5):808–813

    Article  PubMed  Google Scholar 

  28. Quan ML, Hodgson N, Lovrics P, Porter G, Poirier B, Wright FC (2008) National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience. Breast J 14:421–427

    Article  PubMed  Google Scholar 

  29. Carlson RW, Anderson BO, Chopra R et al (2003) Treatment of breast cancer in countries with limited resources. Breast J 9(Suppl 2):S67–S74

    Article  PubMed  Google Scholar 

  30. Olopade OI, Schwartsmann G, Saijo N, Thomas CR Jr (2006) Disparities in cancer care: a worldwide perspective and roadmap for change. J Clin Oncol 24:2135–2136

    Article  PubMed  Google Scholar 

  31. Vanderveen KA, Paterniti DA, Kravitz RL, Bold RJ (2007) Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol 14:1662–1669

    Article  PubMed  Google Scholar 

  32. Davis KG, Schriver JP (2002) Prevalence of teaching sentinel lymph node biopsy for breast cancer in general surgery residency programs. Curr Surg 59:420–422

    Article  PubMed  Google Scholar 

  33. Angarita FA, Acuna SA, Cervera S, Torregrosa L, Tawil M (2012) Meeting surgical necessities for sentinel lymph node biopsy in breast cancer: experience with methylene blue in a Colombian hospital. Breast J 18(6):618–619

    Article  PubMed  Google Scholar 

  34. Gallegos-Hernandez JF, Chavez-Garcia MA, Najera I, Ramirez-Ramirez L, Duran-Martinez M (2003) Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Gac Med Mex 139:205–208

    PubMed  Google Scholar 

  35. Chintamani Tandon M, Mishra A, Agarwal U, Saxena S (2011) Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer–a prospective study. World J Surg Oncol 9:19

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Golshan M, Nakhlis F (2006) Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J 12:428–430

    Article  PubMed  Google Scholar 

  37. Varghese P, Mostafa A, Abdel-Rahman AT et al (2007) Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer. Eur J Surg Oncol 33:147–152

    Article  CAS  PubMed  Google Scholar 

  38. Krikanova M, Biggar M, Moss D, Poole G (2010) Accuracy of sentinel node biopsy for breast cancer using blue dye alone. Breast J 16:384–388

    PubMed  Google Scholar 

  39. Clarke D, Newcombe RG, Mansel RE, ALMANAC Trialists Group (2004) The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 11:211S–215S

    PubMed  Google Scholar 

  40. Sanidas EE, de Bree E, Tsiftsis DD (2003) How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg 185:202–210

    Article  PubMed  Google Scholar 

  41. Quan ML, Wells BJ, McCready D, Wright FC, Fraser N, Gagliardi AR (2010) Beyond the false negative rate: development of quality indicators for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 17:579–591

    Article  PubMed  Google Scholar 

  42. Acuna SA, Angarita FA, McCready DR, Escallon J (2013) Quality indicators for sentinel lymph node biopsy: Is there room for improvement? Can J Surg 56:82–88

    Article  PubMed Central  PubMed  Google Scholar 

  43. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was financed by The Marvelle Koffler Breast Centre, Mount Sinai Hospital, Toronto, Canada.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jaime Escallon.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 103 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Acuna, S.A., Angarita, F.A. & Escallon, J. Assessing Patterns of Practice of Sentinel Lymph Node Biopsy for Breast Cancer in Latin America. World J Surg 38, 1077–1083 (2014). https://doi.org/10.1007/s00268-013-2382-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-013-2382-1

Keywords

Navigation